Health
US to resume use of J&J COVID vaccine – Riverine Herald
The United States can resume use of Johnson & Johnson’s COVID-19 vaccine immediately, health regulators say, ending a 10-day pause to investigate the vaccine’s link to extremely rare but potentially deadly blood clots.The US Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) said in a joint statement on Friday that health systems and vaccine recipients would be warned of the risk of a potentially fatal syndrome involving severe blood clots and low platelets.
…
-
General11 hours agoVictorian school teacher charged with soliciting child abuse material
-
Business20 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
Business22 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business19 hours agoHere’s what analysts expect for the BHP share price in the coming year